Related by context. All words. (Click for frequent words.) 70 immune suppression 68 immunosuppressive agents 68 corticosteroid therapy 67 immunosuppressive drugs 67 immunosuppressive medications 67 immunosuppressive regimen 66 androgen deprivation 66 immunosuppressants 65 myeloablative 65 nephrotoxicity 64 chronic GVHD 64 CMV disease 64 immunosuppressive therapies 64 mycophenolate mofetil 64 GVHD 63 immunosuppressant drugs 63 HSCT 63 immunosuppressive therapy 63 immunosuppressant therapy 63 IFN alpha 63 androgen ablation 63 allogeneic transplantation 63 Immunosuppression 63 allogeneic stem cell 63 immunosuppressive medication 63 immunological 62 immunosuppressive regimens 62 glucocorticoid 62 immuno suppressive 62 renal allograft 62 Cyclosporine 62 systemic corticosteroid 62 allogeneic SCT 62 immuno suppressive drugs 62 CMV infection 62 immune suppressing 62 immune reconstitution 62 HAART regimen 61 cytotoxic chemotherapy 61 cisplatin chemotherapy 61 glucocorticoid therapy 61 immuno suppression 61 allogeneic hematopoietic stem cell 61 interferon IFN 61 engraftment 61 immunologic 61 fulvestrant 61 GnRH agonists 61 antiviral therapy 61 cranial irradiation 61 transplantation HCT 61 pyrazinamide 61 immunosuppressives 61 antibody responses 60 systemic toxicity 60 basiliximab 60 intravenous cyclophosphamide 60 imatinib therapy 60 antimicrobial prophylaxis 60 bone marrow suppression 60 thrombotic complications 60 antirejection drugs 60 hematologic toxicity 60 somatostatin analogs 60 immunosuppressant medication 60 CMV infections 60 glucocorticoids 60 immunosuppressive 60 autologous hematopoietic stem cell 60 chemoradiotherapy 60 therapeutic regimens 60 adalimumab 60 LHRH agonists 60 vWF 60 uric acid lowering 60 EBV infection 60 immunodeficient 60 immunosuppressant medications 60 hemodilution 59 immune suppressants 59 immunopathology 59 myelosuppression 59 antithrombotic therapy 59 hyperalgesia 59 pharmacokinetic interactions 59 renal transplantation 59 calcineurin inhibitors 59 androgen suppression 59 adrenal suppression 59 HCV infected 59 calcineurin inhibitor 59 immunosuppressant 59 ciclosporin 59 systemic immunosuppressive 59 SSc 59 paricalcitol 59 multiorgan 59 corticosteroid 59 immune suppressant 59 immunosuppressant drug 59 CsA 59 posttransplant 59 radioiodine therapy 59 preoperative chemotherapy 59 warfarin therapy 59 FVIII 59 posaconazole 59 corticosteroids 59 ovarian stimulation 59 allogeneic transplant 59 activin 59 azacitidine 59 trastuzumab Herceptin ® 59 retransplantation 59 TNF antagonist 59 antifungal therapy 59 lupus nephritis 59 allogeneic bone marrow 59 methotrexate therapy 59 antioxidant supplementation 59 erythropoietic 59 rFVIIa 59 platelet inhibition 59 d4T stavudine Zerit 59 acute GvHD 59 platelet reactivity 59 coagulopathy 59 HAART 59 premedication 59 renal toxicity 59 cytotoxic effects 59 TNF α 59 remyelination 59 immunosuppression therapy 59 mycophenolate mofetil MMF 59 hormonal therapy 58 pneumonectomy 58 APTIVUS r 58 transgene expression 58 rhTSH 58 cytoreduction 58 IFN beta 58 severe rotavirus gastroenteritis 58 tacrolimus 58 TNFa 58 immunomodulators 58 pyrimethamine 58 imatinib 58 viremia 58 Liver transplantation 58 lymphoid organs 58 CYP #A# 58 antibiotic prophylaxis 58 GnRH agonist 58 antiangiogenic therapy 58 hypercalcemia 58 bisphosphonate therapy 58 transaminase elevations 58 IGFBP 3 58 adjuvant therapy 58 pulmonary artery banding 58 mRCC 58 thrombocytosis 58 dexrazoxane 58 erythropoiesis 58 liver transplant recipients 58 virological response 58 PTLD 58 trimethoprim sulfamethoxazole 58 Natalizumab 58 Cardiopulmonary bypass 58 antithymocyte globulin 58 RBC transfusions 58 anticoagulation 58 autologous transplants 58 interferon 58 gemifloxacin 58 HbF 58 β blockers 58 DAPT 58 dose cyclophosphamide 58 inotropic 58 Host Disease GvHD 58 intravenous bisphosphonates 58 serum phosphate 58 IFN ß 58 nephrotoxic 58 H. pylori eradication 58 virologic failure 58 idraparinux 58 CMV reactivation 58 GRNOPC1 cells 58 decitabine 58 allogeneic HSCT 58 Gleevec resistant 58 pheochromocytoma 58 antiangiogenic 58 potent antiretroviral therapy 58 neurotrophic 58 chlamydial 58 severe neutropenia 58 serum calcium levels 58 Helicobacter pylori eradication 58 CD4 + cells 58 viral suppression 58 cerebral ischemia 58 lung fibrosis 58 infliximab 58 ADPKD 58 biologic therapy 58 Kinoid 57 disease progression 57 ganciclovir 57 Dasatinib 57 nonpharmacologic 57 antiplatelet therapy 57 BCG refractory 57 humoral 57 primidone 57 weekly subcutaneous injections 57 efalizumab 57 neutrophil counts 57 mitomycin C 57 transplanted islets 57 proliferative diabetic retinopathy 57 immune responses 57 antibody mediated 57 invasive candidiasis 57 postoperative AF 57 immunomodulatory therapy 57 thromboprophylaxis 57 NAbs 57 immunological responses 57 beta agonists 57 systemic corticosteroids 57 cytomegalovirus infection 57 serum creatinine levels 57 antitumor effect 57 pegfilgrastim 57 transgenic rats 57 alkaline phosphatase ALP 57 postoperative radiotherapy 57 paroxysmal AF 57 stem cell transplantation 57 virological failure 57 levodopa therapy 57 thrombocytopenic 57 GvHD 57 bleomycin 57 antihypertensive therapy 57 nephrectomy 57 allograft rejection 57 cyclosporin 57 busulfan 57 antibiotic therapy 57 probiotic supplementation 57 reperfusion injury 57 pentoxifylline 57 endotoxemia 57 tumor lysis syndrome 57 adverse cytogenetics 57 peginterferon 57 pharmacologic intervention 57 azathioprine 57 Noxafil 57 rhGH 57 lymph node dissection 57 riociguat 57 pyridostigmine 57 alteplase 57 HBV infection 57 Torisel 57 FASLODEX 57 cyclosporine 57 SIV infection 57 interferon alpha 57 IVIG therapy 57 erlotinib Tarceva 57 TNF alpha antagonist 57 acetabular dysplasia 57 DMARD 57 Tacrolimus 57 SHPT 57 bevacizumab Avastin ® 57 myopathy rhabdomyolysis 57 effector T 57 hyperparathyroidism 57 MGd 57 mixed hyperlipidemia 57 hematopoietic cells 57 vasopressor 57 lichen planus 57 p# activation 57 intra articular injection 57 neutropenic patients 57 pamidronate 57 oral anticoagulation 57 adriamycin 57 allogeneic 57 antitumor efficacy 57 donor marrow 57 inducible nitric oxide synthase 57 bezafibrate 57 DMARD therapy 57 basal cell nevus syndrome 57 pharmacologic approaches 57 adalimumab Humira 57 pulmonary artery hypertension 57 mitochondrial toxicity 57 allogenic 57 sCD# 57 lenalidomide dexamethasone 57 hepatic metastases 57 aromatase inhibitor therapy 57 adjuvant radiotherapy 57 HER2 overexpression 57 opioid analgesia 57 humoral responses 57 Th2 cytokines 57 alefacept 57 lipid lowering therapies 57 intrathecal chemotherapy 57 pegylated interferon alfa 2b 57 ACZ# 57 sulfasalazine 57 combination antiretroviral therapy 57 Toxicities 57 lymphoid 57 steroid dexamethasone 57 recurrent glioblastoma multiforme 57 hypoxemia 57 neoplastic 57 haematopoietic 57 5FU 57 fibrinolysis 57 pancreatic adenocarcinoma 57 adrenal insufficiency 57 DFMO 57 fluvastatin 57 TNFalpha 56 mAbs 56 L dopa 56 proinflammatory cytokine 56 prophylactic treatment 56 HLA matched 56 Corticosteroids 56 tumor recurrence 56 TGF β 56 serum HBV DNA 56 calcitriol 56 Candida infection 56 inhaled bronchodilators 56 hematopoietic stem cell 56 HIV HCV coinfected 56 ritonavir boosted 56 mucosal immune responses 56 protease inhibitor PI 56 hA# 56 Adjuvant chemotherapy 56 GISTs 56 humoral immunity 56 alkylating agent 56 hematopoietic cell 56 aldosterone antagonist 56 hypersensitivity reaction 56 Neoral 56 COPD exacerbations 56 CHOP chemotherapy 56 anti leukemic 56 pegylated liposomal doxorubicin 56 CellCept mycophenolate mofetil 56 intravenous immunoglobulin 56 renoprotective 56 postoperative morbidity 56 antidepressant therapy 56 anthracycline therapy 56 Rituximab 56 EXJADE 56 GHRH 56 isoproterenol 56 NRTIs 56 anakinra 56 CMV seropositive 56 Trastuzumab 56 intracranial hemorrhage ICH 56 urothelial bladder cancer 56 cytotoxicity 56 neutralizing antibody 56 pegylated interferon alfa 56 platelet activation 56 tibolone 56 interleukin IL -# 56 ADAMTS# 56 nonmyeloablative 56 kidney allograft 56 adrenalectomy 56 activate p# 56 cystectomy 56 hepatorenal syndrome 56 surgical debulking 56 renal dysfunction 56 Bcl xL 56 Ribavirin causes 56 antiretroviral regimens 56 TRAIL induced apoptosis 56 transplantation HSCT 56 androgen therapy 56 postoperative chemotherapy 56 canakinumab 56 Cremophor 56 cytoprotective 56 chemosensitivity 56 Doxil ® 56 adrenal function 56 chemotherapeutic regimens 56 intradermal injection 56 ischemia reperfusion injury 56 verapamil 56 relapsed MM 56 lenalidomide Revlimid R 56 receiving immunosuppressive therapy 56 pretransplant 56 genotypic resistance 56 potentiation 56 immunocompetent 56 IFN gamma 56 TKI therapy 56 Interferon alpha 56 pegylated IFN 56 torsade de pointes 56 hepatic glucose production 56 hydroxychloroquine 56 solid organ transplantation 56 amyloid deposition 56 allogeneic hematopoietic cell 56 beta blocker therapy 56 leukemia AML 56 antiandrogens 56 NF kB pathway 56 cidofovir 56 antiandrogen 56 airway hyperresponsiveness 56 arteriovenous fistula 56 Mild hypothermia 56 microvascular complications 56 cranial radiation 56 hepatocellular 56 heavily pretreated 56 d4T 56 cytopenias 56 NSAID therapy 56 type 1diabetes 56 G CSF 56 HuR 56 antibody titers 56 hypoperfusion 56 gonadotropins 56 interferon therapy 56 mTOR inhibitors 56 chemo radiotherapy 56 thrombotic events 56 moderate renal impairment 56 IL 1ß 56 visilizumab 56 mucosal healing 56 renal fibrosis 56 anemia hemoglobin 56 postexposure 56 aldosterone antagonists 56 CD8 T cell 56 protease inhibitors PIs 56 mg kg dose 56 statin therapy 56 methotrexate 56 refractory gout 56 genotoxic stress 56 Anthracycline 56 TGF beta signaling 56 excitotoxic 56 organ rejection 56 gastrointestinal toxicity 56 neutralizing antibodies 56 Mitoxantrone 56 Etanercept 56 CD4 + T 56 cardiac toxicity 56 microglial activation 56 daunorubicin 56 prothrombotic 56 metastatic neuroendocrine tumors 56 seropositive patients 56 EBRT 56 soluble CD# 56 parathyroid hormone PTH 56 lymphocytosis 56 corifollitropin alfa 56 bowel resection 56 myelosuppressive 56 thromboembolic events 56 hypertrophic scarring 56 radiochemotherapy 56 Fludarabine 56 hematopoietic cancers 55 rituximab 55 sotalol 55 octreotide 55 neovascularisation 55 effector function 55 intensity allogeneic stem 55 KRAS status 55 palifermin 55 antiemetics 55 cinacalcet 55 anti TNF 55 allogeneic transplants 55 serum urate levels 55 anthracycline taxane 55 antiplatelet therapies 55 atopic disease 55 systemic absorption 55 toxicities 55 VTE prophylaxis 55 TroVax ® 55 acute GVHD 55 NATRECOR ® 55 plasma kallikrein 55 LHRH agonist 55 left ventricular dysfunction 55 valproic acid 55 immune globulins 55 insulin detemir 55 Bacillus Calmette Guerin BCG 55 inhaled glucocorticoids 55 C1 INH deficiency 55 arterial calcification 55 sirolimus 55 ovarian carcinoma 55 atherosclerotic disease 55 cervical lymph nodes 55 aminotransferases 55 esophagitis 55 perioperative complications 55 hepatotoxicity 55 cART 55 gastrointestinal stromal tumors GIST 55 growth hormone secretion 55 Treg cell 55 neoadjuvant therapy 55 hypotensive 55 EGFR antibodies 55 oral anticoagulants 55 amenorrhea 55 indolent NHL 55 cabazitaxel 55 virologic response 55 stavudine 55 disease modifying antirheumatic 55 graft dysfunction 55 suppressor cells 55 rituximab Rituxan 55 hyperkalemia 55 Graft versus 55 cyclophosphamide 55 pimecrolimus 55 Thrombocytopenia 55 transfusion transmitted 55 anthracycline chemotherapy 55 tumor shrinkage 55 metastatic RCC 55 HBV replication 55 beta interferon 55 olmesartan 55 delayed CINV 55 exogenous insulin 55 antihypertensive drugs 55 nitroprusside 55 oral clodronate 55 CD4 + T lymphocytes 55 APTIVUS 55 effector memory 55 haematologic 55 CTAP# Capsules 55 B7 H3 55 DOXIL 55 saline placebo 55 prophylactically 55 transplantation 55 fibrinolytic therapy 55 HBeAg negative 55 malarial anemia 55 HPA axis suppression 55 nephrotoxic drugs 55 NF kappaB activation 55 VZV 55 treatment regimens 55 KETEK 55 boosted protease inhibitor 55 idarubicin 55 danazol 55 candidemia 55 ovariectomy 55 antiepileptic drugs AEDs 55 suppressive therapy 55 pDCs 55 colorectal liver metastases 55 Hydroxyurea 55 vWD 55 GIST tumors 55 mCRC patients 55 GH deficiency 55 inflammatory cytokine 55 osteoblastic 55 CIMZIA ™ 55 alpha blocker 55 follistatin 55 Neulasta ® 55 ALT flares 55 transaminase levels 55 skeletal metastases 55 loop diuretics 55 DMARDS 55 interferon beta 55 venous thromboembolic events 55 N. gonorrhoeae 55 immunosuppressed 55 fibrinolytic 55 dose cytarabine 55 gemcitabine Gemzar 55 neoadjuvant chemotherapy 55 uPA 55 immuno suppressants 55 ovulatory cycles 55 Immunosuppressive drugs 55 antimuscarinic 55 postoperative mortality 55 NNRTI resistance 55 3TC lamivudine Epivir 55 tardive dyskinesia TD 55 antiretroviral therapy 55 mg/m2 dose 55 factor G CSF 55 platelet transfusions 55 TNF inhibitors 55 CLL cells 55 cell transplantation 55 immunomodulatory effects 55 thyroxine 55 coadministration 55 intensive statin therapy 55 biologic DMARD 55 potentially hepatotoxic 55 pertussis toxin 55 proteoglycan 55 mitoxantrone 55 thromboembolic disease 55 testosterone supplementation 55 Surgical excision 55 oral anticoagulant therapy 55 virologic responses 55 orchiectomy 55 methimazole 55 Human cl 55 lung metastasis 55 hemorrhagic complications 55 Cell Lymphoma CTCL 55 anthracyclines 55 GnRH antagonist 55 chlorambucil 55 nitrofurantoin 55 Hb levels 55 iron supplementation 55 C1 INH 55 experimentally induced 55 disease GVHD 55 hepatectomy 55 motor neuron degeneration 55 tumor necrosis 55 Combination therapy 55 empiric treatment 55 purpura ITP 55 interferon alfa 55 TNF inhibitor 55 oral antidiabetic medication 55 saphenous vein grafts 55 anti androgen 55 trans retinoic acid 55 nitazoxanide 55 anticoagulation therapy 55 vasodilators 55 cerebral vasospasm 55 anticoagulant therapy 55 autoimmune reactions 55 PEGylated interferon beta 1a 55 TMP SMX 55 leukemic blasts 55 denervation 55 CellCept 55 osteosarcomas 55 nucleoside analogues 55 Lenalidomide 55 autoimmunity 55 CIMZIA TM 55 basal cell carcinoma BCC 55 Myelofibrosis 55 CD# upregulation 55 T2DM 55 macroalbuminuria 55 pulmonary hypertension PH 55 cardiotoxic effects 55 metastatic malignant melanoma 55 plasma uric acid 55 ursodeoxycholic acid 55 airway responsiveness 55 Clusterin 55 chlamydial infection 55 concomitant medications 55 reperfusion 55 occlusive disease 55 postprandial glycemia 55 downregulation 55 neutropenic 55 vasoconstriction 55 imatinib resistance 55 overlapping toxicities 55 anticoagulants 55 thromboembolic complications 55 VEGF expression 55 IDH mutations 55 nonoperative treatment 55 sunitinib 55 platelet deficiency 55 NEUPOGEN 55 renal insufficiency 55 serum testosterone 55 dexamethasone Decadron 55 von Willebrand disease 55 ribavirin therapy 55 vasodilatation 55 TORISEL 55 cardiotoxicity 55 nevirapine Viramune 55 membranous nephropathy 55 intimal hyperplasia 55 bladder carcinoma 55 decompensated cirrhosis 55 raltegravir 55 pneumococcal infection 55 LHRH antagonists 55 glycated hemoglobin levels 55 NNRTIs 55 ara C 55 lactic acidosis 55 mismatched bone marrow 55 lipid lowering therapy 55 axonal damage 55 ACTH 55 mesalamine granules 55 antiretroviral regimen 55 inhaled nitric oxide 55 adrenocorticotropic hormone 54 Flu Cy 54 nonischemic 54 voriconazole 54 neovascularization 54 autologous transplantation 54 antiretroviral naive 54 febrile neutropenia 54 lymphopenia 54 L asparaginase 54 Th2 responses 54 dopaminergic therapy 54 PlGF 54 statins cholesterol lowering 54 genital herpes infections 54 nicardipine 54 hypereosinophilic syndrome 54 prophylaxis 54 dose titration 54 hypercalcaemia 54 immune modulating 54 chronic periodontitis 54 T1DM 54 neurocognitive deficits 54 pelvic lymphadenectomy 54 autoantibody levels 54 Th2 cells 54 anthracycline containing 54 empiric therapy 54 haematological toxicity 54 C#BL 6 mice 54 pimozide 54 STN stimulation 54 mutant p# 54 aprepitant 54 antiplatelet agents 54 tryptase 54 fulminant hepatic failure 54 imetelstat 54 INTELENCE 54 chronicity 54 external beam radiotherapy 54 dosage regimens 54 hyperphenylalaninemia HPA due 54 recurrent VTE 54 Hurthle cell 54 intermittent hypoxia 54 cardiotoxic 54 renal function 54 orchitis 54 anticlotting drugs 54 ß blockers 54 mycosis fungoides 54 nephropathy 54 HBeAg seroconversion 54 metaplasia 54 glomerular filtration 54 immunocompromised patients 54 curative resection 54 liver toxicity 54 TNF therapy 54 AV grafts 54 peg interferon 54 N acetylcysteine 54 Aggrastat ® tirofiban hydrochloride 54 perioperatively 54 tamoxifen therapy 54 postexposure prophylaxis 54 APTIVUS ritonavir 54 endothelial cell 54 BYSTOLIC 54 belatacept 54 hyperinsulinemia 54 Lymph node 54 etiologic 54 EGFR TKI 54 colon carcinoma 54 prostate cancer CRPC 54 levodopa carbidopa 54 autologous SCT 54 ZOMETA 54 dosing frequency 54 receptor inhibitor 54 factor TNF 54 Valcyte 54 adult chronic ITP 54 romiplostim 54 Vitamin D insufficiency 54 ouabain 54 rHuEPO 54 standard chemotherapy regimens 54 nucleoside naive patients 54 platelet inhibitor 54 thyrotropin 54 stimulate ovulation 54 MMP inhibitors 54 antiplatelet medications 54 ovarian hormones 54 oxaliplatin Eloxatin 54 von Willebrand 54 Leydig cell 54 fibrosis 54 chronic hemodialysis 54 autonomic dysfunction 54 amenorrhoea 54 artery stenosis 54 immune thrombocytopenic purpura 54 FVIIa 54 mucosal immunity 54 Gleevec imatinib 54 vasoconstrictor 54 steroid refractory 54 ICD therapy 54 severe oral mucositis 54 immunosuppressed patients 54 K ras mutations 54 neutropenic fever 54 vasoactive 54 inotropes 54 radiotherapy RT 54 anticoagulants blood thinners 54 chemotherapy radiotherapy 54 generalized seizures 54 plasminogen activators 54 octreotide LAR 54 HUCB cells 54 endometrial hyperplasia 54 serum cortisol 54 Akt activation 54 alanine aminotransferase ALT 54 PTHrP 54 renal scarring 54 lung epithelium 54 anagrelide 54 corticosteroid dose 54 HCV infection 54 Genetic predisposition 54 primary aldosteronism 54 palliation 54 Nilotinib 54 autoregulation 54 tumorigenicity 54 Kepivance 54 leflunomide 54 hypothalamic pituitary adrenal axis 54 neurologic deficits 54 mutated K ras 54 thrombolytic agents 54 nonadherence 54 Foxp3 54 dose ritonavir 54 adrenocorticotropic hormone ACTH 54 leukaemic stem cells 54 CR nPR 54 MULTAQ 54 postoperative complications 54 PEGylated Fab fragment 54 thyroid stimulating hormone 54 progressive dyspnea 54 adefovir 54 basal cell carcinomas 54 poliovirus vaccine 54 hepatic 54 PREZISTA r 54 gastric carcinoma 54 idiopathic thrombocytopenic purpura 54 deacetylation 54 tocilizumab 54 heterozygous FH 54 abatacept 54 inhibin 54 Advagraf 54 sarcomatoid 54 highly immunogenic 54 liver histology 54 PAOD 54 macrovascular complications 54 iron overload 54 metastatic lesions 54 grade dysplasia 54 sodium stibogluconate 54 myocardial reperfusion 54 CD4 + 54 mutated KRAS gene 54 epirubicin 54 Pioglitazone 54 strong CYP#A# inducers 54 relapsing multiple sclerosis 54 nelfinavir 54 granulocyte 54 Endothelial 54 malabsorptive 54 S. aureus colonization 54 bacterial prostatitis 54 EGFR tyrosine kinase inhibitors 54 trastuzumab 54 menstrual migraine 54 carcinoids 54 islet transplant 54 interferons 54 selective inhibition 54 isoenzyme 54 EGFR inhibitors 54 cytoreductive surgery 54 mepolizumab 54 breast carcinoma 54 CP CPPS 54 experimental autoimmune encephalomyelitis 54 Hashimoto thyroiditis 54 lymphadenopathy 54 bacillus Calmette Guerin 54 intravesical 54 myocardial dysfunction 54 lymphoproliferative disorder 54 sJIA 54 tipranavir ritonavir 54 aminoglycoside 54 autologous transplant 54 malperfusion 54 ImmuKnow 54 pig islets 54 lipoatrophy 54 teriparatide 54 hepatoma 54 granulomatous 54 postoperative complication 54 grade glioma 54 Cytoxan 54 azacytidine 54 IGFBP 54 lymphocytic 54 prednisone steroid 54 eradicate H. pylori 54 microvascular dysfunction 54 upregulating 54 mcg dose 54 VEGF inhibitors 54 neurologic complications 54 Prophylaxis 54 iNOS